Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02804906
Other study ID # 16-00554
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 2016
Est. completion date January 14, 2019

Study information

Verified date January 2020
Source NYU Langone Health
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This pilot feasibility study will test whether a home-based cardiac rehabilitation intervention, using physical therapist visits combined with mobile health technology, will prevent decline in high-risk patients post acute myocardial infarction (AMI). Participants will be randomized to either an intervention arm (home-based physical therapy), or a control (usual care) arm. Prior to discharge, participants in the intervention arm will receive a 1-hour educational session by a research physical therapist that includes information on cardiac risk factor management, postoperative recovery, education on medication adherence, and a prescription for home exercise that is tailored to each patient's baseline abilities and limitations. Participants assigned to the control arm will receive a 30-minute counseling session on risk factor modification prior to discharge, in addition to usual care post-AMI.


Description:

All participants enrolled in this research study will receive the FDA-approved FitBit Flex, a wearable activity monitoring device which will objectively measure physical activity and sedentary behavior in the period post-hospital discharge. Daily activity monitoring will include: number of steps, distance traveled, calories burned, number of active minutes.


Recruitment information / eligibility

Status Completed
Enrollment 27
Est. completion date January 14, 2019
Est. primary completion date December 14, 2018
Accepts healthy volunteers No
Gender All
Age group 70 Years and older
Eligibility Inclusion Criteria:

- Clinical diagnosis of acute myocardial infarction (AMI).

Exclusion Criteria:

- moderate to severe cognitive impairment; non-ambulatory

- severe heart failure (NYHA Class IV); decisional impairment as assessed by the University of California

- San Diego Brief Assessment of Capacity to Consent (UBACC) 22, if the RC questions capacity; very limited life expectancy (e.g. anticipated discharge to hospice)

- non-English/non-Spanish speaking.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Home-based physical therapy
Participants will be visited by a physical therapist 3 times a week for approximately 1 hour each day, for a duration of 4 weeks. These visits will serve to encourage adherence to the intervention, reinforce activities recommended at discharge, monitor safety under direct supervision, and adjust the exercise prescription if/as needed (e.g. advance recommended activity level) if necessary. Patients will also be provided with a tablet computer device installed with software, Moving Analytics, that will reinforce the cardiac rehabilitation program through daily reminders and easily accessible visual activity plans. This program will be updated by the physical therapist during home visits as the program advances. Daily patient-reported health status ("Your Activities of Daily Living") 26 will be ascertained on the same tablet device by participants three times per week using open source software designed.
Usual Care
Participants in the control arm will be provided with a 30-minute counseling session on risk factor modification prior to discharge. Participants will be provided with a tablet computer device to complete patient-reported health status ("Your Activities of Daily Living") 26 three times per week using open source software designed. Participants will be visited by the Research Coordinator or member of the study team at one month post-hospital discharge to perform a follow-up assessment that will include ADLs, IADLs, SF-12 PCS, frailty measures, and questions on healthcare utilization (hospital readmissions).

Locations

Country Name City State
United States New York University School of Medicine New York New York

Sponsors (1)

Lead Sponsor Collaborator
NYU Langone Health

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Activities of Daily Living (ADL) Decline Assessment of the functional dependence or independence in carrying out activities of daily living, including bathing, dressing, toileting, transferring, continence, and feeding. 5 Weeks
Secondary Decline in self-perceived physical health (measured by SF-12 PCS) Health status measure that addresses both physical and mental health. 5 Weeks
Secondary Mean time spent in sedentary activity 5 Weeks
Secondary Mortality Rate 5 Weeks
Secondary Hospital readmission rate 5 Weeks
See also
  Status Clinical Trial Phase
Completed NCT01463475 - University of Wisconsin hMSC Cell Bank: Bone Marrow Donor Protocol N/A
Completed NCT02290080 - Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers Phase 3
Completed NCT00211172 - HMO Research Network CERT: Acute Myocardial Infarction N/A
Completed NCT03725826 - Risk Stratification After Acute Myocardial Infarction With Cardiac MRI
Not yet recruiting NCT06118281 - ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack Phase 3
Completed NCT01890018 - Partners and Alerts: A Study of Social Forces in Medication Adherence N/A
Completed NCT05696379 - Angiography Derived Index of Microcirculatory Resistance in Patients With Acute Myocardial Infarction
Recruiting NCT02018497 - Essential Hypotension and Allostasis Registry
Completed NCT00833612 - Counterpulsation Reduces Infarct Size Pre-PCI for AMI Phase 4
Completed NCT00781118 - AngelMed for Early Recognition and Treatment of STEMI Phase 3
Not yet recruiting NCT04835207 - Metabolic Profile as a Predictor of No-reflow in Diabetic Patients